Specialty in vitro diagnostics company Eurobio Scientific has announced the cancellation of 694,300 treasury shares, representing 6.34% of its share capital, effective January 11.

Its share capital will now consist of 10,248,871 shares. Following this cancellation, Eurobio Scientific still directly holds 184,883 of its own shares, plus shares held under the liquidity contract.

Copyright (c) 2024 CercleFinance.com. All rights reserved.